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Perineuronal nets (PNNs) are an extracellular matrix structure rich in chondroitin sulfate proteoglycans (CSPGs), which preferentially
encase parvalbumin-containing (PV1) interneurons. PNNs restrict cortical network plasticity but the molecular mechanisms involved
are unclear. We found that reactivation of ocular dominance plasticity in the adult visual cortex induced by chondroitinase ABC
(chABC)-mediated PNN removal requires intact signaling by the neurotrophin receptor TRKB in PV1 neurons. Additionally, we dem-
onstrate that chABC increases TRKB phosphorylation (pTRKB), while PNN component aggrecan attenuates brain-derived neurotro-
phic factor (BDNF)-induced pTRKB in cortical neurons in culture. We further found that protein tyrosine phosphatase r (PTPr,
PTPRS), receptor for CSPGs, interacts with TRKB and restricts TRKB phosphorylation. PTPr deletion increases phosphorylation of
TRKB in vitro and in vivo in male and female mice, and juvenile-like plasticity is retained in the visual cortex of adult PTPr-deficient
mice (PTPr1/2). The antidepressant drug fluoxetine, which is known to promote TRKB phosphorylation and reopen critical period-
like plasticity in the adult brain, disrupts the interaction between TRKB and PTPr by binding to the transmembrane domain of
TRKB. We propose that both chABC and fluoxetine reopen critical period-like plasticity in the adult visual cortex by promoting
TRKB signaling in PV1 neurons through inhibition of TRKB dephosphorylation by the PTPr-CSPG complex.
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Significance Statement
Critical period-like plasticity can be reactivated in the adult visual cortex through disruption of perineuronal nets (PNNs) by
chondroitinase treatment, or by chronic antidepressant treatment. We now show that the effects of both chondroitinase and
fluoxetine are mediated by the neurotrophin receptor TRKB in parvalbumin-containing (PV1) interneurons. We found that
chondroitinase-induced visual cortical plasticity is dependent on TRKB in PV1 neurons. Protein tyrosine phosphatase s
(PTPs , PTPRS), a receptor for PNNs, interacts with TRKB and inhibits its phosphorylation, and chondroitinase treatment or
deletion of PTPs increases TRKB phosphorylation. Antidepressant fluoxetine disrupts the interaction between TRKB and
PTPs , thereby increasing TRKB phosphorylation. Thus, juvenile-like plasticity induced by both chondroitinase and antide-
pressant treatment is mediated by TRKB activation in PV1 interneurons.
Introduction
Plasticity is the ability of the brain to change itself through estab-
lishing new neuronal connections and rewiring existing ones.
Plasticity is prominent in early life and it peaks during so-called
“critical periods” when the ability of the brain to adapt is at its
highest (Wiesel, 1982). After the end of the critical period, plas-
ticity persists but at significantly diminished levels (Hübener and
Bonhoeffer, 2014).
Closure of the critical periods is mediated by changes in corti-
cal excitatory/inhibitory (E/I) balance that take place because of
maturation of cortical inhibitory interneurons. Fast-spiking
interneurons expressing parvalbumin (PV1) orchestrate syn-
chronous neuronal oscillations and play a particularly important
role in this process (Hensch, 2005). Closure of the critical period
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coincides with the functional maturation of PV1 cells and estab-
lishment of perineuronal nets (PNNs) around them (Wang and
Fawcett, 2012; Umemori et al., 2018; Fawcett et al., 2019).
PNNs are mesh-like structures of extracellular matrix that sur-
round the somata and proximal dendrites of PV1 interneurons
in particular (Kwok et al., 2011). Chondroitin sulfate proteogly-
cans (CSPGs), such as aggrecan and brevican, are major com-
ponents of PNNs.
After the closure of a critical period, neuronal plasticity can
still be modulated, and critical period-like plasticity can be
induced in the adult brain by a number of different methods
(Bavelier et al., 2010; Sale et al., 2014). Digestion of PNNs by
chondroitinase ABC (chABC) treatment has been demonstrated
to induce ocular dominance plasticity in the adult visual cortex
(Pizzorusso et al., 2002). Local chondroitinase injections into dif-
ferent brain areas have also been shown to promote recovery of
spinal cord injury (Bradbury et al., 2002) and extinction of fear
memories in adult rodents (Gogolla et al., 2009; Hylin et al.,
2013; Shi et al., 2019). However, the mechanisms through which
chABC influences plasticity in the CNS remain unclear.
Antidepressant drugs also induce critical period-like plastic-
ity in the adult brain (Castren, 2013). Antidepressants activate
neurotrophic receptor tyrosine kinase 2 (TRKB), the receptor
for brain-derived neurotrophic factor (BDNF), and promote
plasticity through its signaling pathways (Saarelainen et al.,
2003; Duman and Monteggia, 2006; Castrén and Antila, 2017;
Umemori et al., 2018). Like ChABC, fluoxetine, a widely pre-
scribed antidepressant, induces ocular dominance plasticity in
the rodent visual cortex (Maya Vetencourt et al., 2008) and
makes fear-related memories in mice susceptible to erasure
(Karpova et al., 2011). We have recently found that the activa-
tion of TRKB in PV1 interneurons is both necessary and suffi-
cient for antidepressant-induced plasticity in the mature CNS
(Winkel et al., 2020).
ChABC and antidepressant treatment exert similar plastic-
ity-promoting effects in the adult brain; however, it is not
known whether they recruit similar molecular mechanisms. We
hypothesize that receptor-like protein tyrosine phosphatase s
(PTPs ) might be a nexus that mediates plasticity processes
induced by both methods. PTPs is a receptor for CSPGs (Shen
et al., 2009), and it has been demonstrated to be essential for
the inhibitory effects of CSPGs on neurite outgrowth (Shen et
al., 2009; Duan and Giger, 2010; Coles et al., 2011). PTPs inter-
acts with and modulates the activity of TRK receptors (Faux et
al., 2007; Takahashi et al., 2011), inhibiting TRKB through de-
phosphorylation (Kurihara and Yamashita, 2012).
We now demonstrate that TRKB activity in PV1 interneur-
ons is essential for plasticity induced by chABC. While CSPGs
removal by chABC injection into the visual cortex promotes ocu-
lar dominance shift, this effect is abolished in heterozygous mice
with reduced TRKB in PV1 neurons (PV-TRKB1/). We have
confirmed that PTPs interacts with TRKB, and genetic defi-
ciency of PTPs promotes TRKB phosphorylation (pTRKB) in
vitro and in vivo. We further show that PTPs deficiency pro-
motes plasticity at network levels, as PTPs1/ mice display criti-
cal period-like plasticity in the visual cortex in adulthood.
Finally, we have observed that the antidepressant fluoxetine dis-
rupts TRKB:PTPs interaction in vitro and in vivo.
Materials and Methods
Animals
BALB/c and C57BL/6J mice heterozygous for PTPRS gene (PTPs1/
mice) and their wild-type (WT) littermates, C57BL/6J mice heterozygous
for TRKB gene in PV1 interneurons (PV-TRKB1/) and their PV-Cre
littermates (PV-TRKB1/1), WT C57BL/6J mice were used in the experi-
ments. BALB/c PTPs1/ mice were originally developed by Michel
Tremblay’s lab (McGill University, Canada; Elchebly et al., 1999) and
kindly donated to us by Heikki Rauvala (University of Helsinki). BALB/
c PTPs1/ mice 10weeks old were used for brain sample collection and
pTRKB level assessment by ELISA. For optical imaging experiments,
BALB/c mouse line was rederived to C57BL/6J background, and N4 gen-
eration of the offspring was used for testing. The mice were twomonths
old at the beginning of the experiments. PV-TRKB1/ (TRKBflx/wt,
PVcre/wt) mice were generated by mating heterozygous floxed TRKB
mice (TRKBflx/wt; Minichiello et al., 1999) and homozygous PV-specific
Cre line (PVcre/cre; Pvalb-IRES-Cre, JAX: 008069, The Jackson
Laboratory; Hippenmeyer et al., 2005). PV heterozygous (TRKBw/w,
PVcre/wt) littermates with intact TRKB in PV1 neurons were used as a
control group for PV-TRKB1/ mice. The mice were fourmonths old at
the beginning of the experiments. WT C57BL/6J mice fivemonths old
were used to assess fluoxetine effect on TRKB:PTPs interaction in the
visual cortex in vivo. The mice were kept under standard laboratory con-
ditions with 12/12 h light/dark cycle (lights on at 6 A.M.) and access to
food and water ad libitum. All the procedures involving animals were
done in compliance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals guidelines and were approved by
the Experimental Animal Ethical Committee of Southern Finland
(ESAVI/10 300/04.10.07/2016).
Brain sample collection and processing
Mice were killed with CO2. The death was confirmed by ascertaining
cardiac and respiratory arrest. The animals were decapitated, the visual
cortices were dissected and stored at 80°C. Samples from the primary
visual cortex were sonicated in NP lysis buffer (137 mM NaCl, 20 mM
Tris, 1% NP-40, 10% glycerol, and 48 mM NaF) containing a protease
and phosphatase inhibitor mix (#P2714 and #P0044, Sigma-Aldrich)
and 2 mM Na2VO3. The homogenate was centrifuged for 15min at
15,000  g, 4°C. The supernatant was collected and used for further
analysis. Protein levels were measured using DC Protein Assay kit (Bio-
Rad, #5000116) by colorimetric Lowry method in Varioskan Flash
(Thermo Fisher Scientific).
Cell culture
Cerebral cortical cell cultures were prepared from Wistar rat (Harlan
Labs) embryos extracted on embryonic day (E)18 (Sahu et al., 2019).
The cells were cultured in a serum-free neurobasal medium with supple-
ments (1% penicillin, 1% L-glutamine, 2% B-27) and collected after 7–
9 d in vitro (DIV). For the experiments assessing the effect of PTPs
genetic deficiency on pTRKB in vitro, cortical cell cultures were prepared
from BALB/c mouse embryos (PTPs/, PTPs1/ and their WT litter-
mates) extracted on E18 using the same protocol as described above for
the rat cells. Mouse fibroblast cells stably expressing full-length TRKB
(MG87.TRKB) or TRKA (MG87.TRKA) were cultured in DMEM sup-
plemented with 10% fetal calf serum (FCS), 1% penicillin/streptomycin
(PS), 1% L-glutamine, and 400mg/ml G418. Human-derived HEK293T
cells were cultured in DMEM supplemented with 10% FCS, 1% PS, and
1% L-glutamine.
Transfection
We transfected 70% confluent MG87.TRKA, MG87.TRKB, and HEK293T
cell lines using Lipofectamine 2000 (Thermo Fischer Scientific). MG87.
TRKA andMG87.TRKB cells were transfected with PTPs (RefSeq number
NM_019140) Myc-DDK-tagged open-reading frame (ORF) plasmid pur-
chased from OriGene (#RR209636), pCMV6-Entry vector with C-terminal
Myc-DDK Tag (#PS100001) was used to transfect control cells. HEK293T
were transfected with GFP-tagged full-length TRKB plasmid (HP220GFP-
TRKB; Haapasalo et al., 2001) or TRKB carrying Y433F/R427A mutation
(Cannarozzo et al., 2020).
Antibodies and reagents
Aggrecan was purchased from Sigma-Aldrich (A1960). Anti-phospho-
TRKA (Tyr490)/TRKB (Tyr516; C35G9) rabbit monoclonal antibody
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(mAb) was purchased from Cell Signaling Technology (#4619, #4621,
and #4168). Anti-TRKB goat polyclonal antibody (pAb) was bought
from R&D Systems, #AF1494. Anti-phosphotyrosine mouse monoclonal
antibody (clone PY20) was purchased from Bio-Rad (#MCA2472). Anti-
PTPs (SS-8) mAb was purchased from Santa Cruz Biotechnology
(SC-100419). Secondary horseradish peroxidase (HRP)-conjugated anti-
bodies were purchased from Bio-Rad (goat anti-rabbit #1705046 and
goat anti-mouse #1705047) and from Invitrogen (rabbit anti-goat
#611620). Enhanced chemiluminescent (ECL) substrate WesternBright
Quantum HRP substrate (Advansta) was used for Western blotting
(#K-12042). Pierce HRP ECL substrate was used to detect luminescence
in ELISA (Thermo Fisher Scientific, #32209). Tris-buffered saline with
Tween 20 (TBST) was used for Western blotting (20 mM Tris-HCl, 150
mM NaCl, and 0.1% Tween 20; pH 7.6), PBS with Tween 20 (PBST) was
used for ELISA (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, and 0.1%
Tween 20; pH 7.4).
Drug treatment
We added 10mg/ml aggrecan to cortical neurons cultured 6 DIV, and
the cells were collected 1 d after the aggrecan treatment (7 DIV); 20ng/
ml BDNF was added to cortical cells for 10min; 0.1 and 1 mM fluoxetine
was added to cortical cells cultured 7 DIV, and the cells were collected
after 30min of treatment. HEK293T cells were treated with 10 mM
fluoxetine for 30min. BALB/c PTPs1/ and WT mice were injected
with 30mg/kg fluoxetine intraperitoneally and killed with CO2. The
brain samples were collected and stored at 80°C until further
processing.
Immunoprecipitation and Western blotting
The cells were lysed using NP lysis buffer containing 2 mM sodium
orthovanadate and protease inhibitor mix. The homogenized suspension
was centrifuged (15,000  g, 10min, 14°C), and the resulting superna-
tant was used for analysis. For immunoprecipitation, TRKB was cap-
tured using anti-TRKB antibodies (R&D Systems). The samples were
incubated with Sepharose, washed with NP lysis buffer twice and the
proteins were separated by heating in 2 Laemmli buffer (4% SDS, 20%
glycerol, 10% 2-mercaptoethanol, 0.02% bromophenol blue, and 125 mM
Tris HCl; pH 6.8) for 5min at 95°C. The samples were loaded to
NuPAGE 4–12% Bis-Tris Protein polyacrylamide gels (Invitrogen,
#NP0323BOX), and the proteins were separated according to their mo-
lecular weight using electrophoresis. The samples were transferred to
polyvinylidene difluoride (PVDF) membrane, incubated in 1:1000 pri-
mary antibody dilution in 3% bovine serum albumin (BSA) in tris-phos-
phate buffer containing 0.1% Tween 20 (TBST) overnight at 4°C and
subsequently incubated in HRP-conjugated secondary antibodies
(1:10,000) for 1 h at room temperature (RT). The bands were visualized
Table 1. Statistical analysis and the number of animals/samples used in the experiments
Graph Pre hoc Post hoc N, number of samples/animals per group
1A Three-way ANOVA (time  genotype  drug):
General effect:
Time (IOS): F(1,34) = 4.139, p= 0.0498
p
Genotype: F(1,34) = 0.7739, p= 0.3852
chABC: F(1,34) = 5.164, p= 0.0295
p
Interaction:
Time  genotype: F(1,34) = 4.861, p= 0.0343p
Time  chABC: F(1,34) = 6.483, p= 0.0156p
Genotype  chABC: F(1,34) = 7.244, p= 0.0110p
Time  genotype  chABC: F(1,34) = 5.899, p= 0.0206p
Tukey’s multiple comparison test:
WT-chABC (IOS1)  WT-chABC (IOS2):
p= 0.0002p
WT-vehicle: 3 (we have used the lowest number of animals
possible in the control group to reduce the total number of
animals used in the experiments; there is abundant evi-
dence of no shift in ocular dominance in adult WT mice




1B Mann–Whitney: U= 0, p= 0.0286p Vehicle: 4
chABC: 4
1C Two-way ANOVA:
Interaction: F(1,20) = 3.921, p= 0.0616
BDNF: F(1,20) = 155.2, p, 0.0001
p
Aggrecan: F(1,20) = 5.117, p= 0.035
p











F(2,14) = 91.44, p, 0.0001
p
Tukey’s multiple comparison test: WT 
PTPs1/: p= 0.0007p
WT  PTPs -/-: p, 0.0001p




2D Mann–Whitney: U= 0, p= 0.0002p WT: 7
PTPs1/: 9
2E Mann–Whitney: U= 9, p= 0.0164p WT: 7
PTPs1/: 9
2F Two-way ANOVA:
Interaction: F(1,8) = 33,13, p= 0.0004
p
Time: F(1,8) = 40.81, p= 0.0002
p
Genotype: F(1,8) = 36.70, p= 0.0003
p
Bonferroni’s multiple comparison test:





F(2,15) = 6.734, p= 0.0082
p
Bonferroni’s multiple comparison test:
vehicle  fluoxetine 1 mM: p= 0.0046p
Vehicle: 6
Fluoxetine 0.1 mM: 6
Fluoxetine 1 mM: 6
3B Unpaired t test: t(6) = 4.025, p= 0.0069
p Vehicle: 4
Fluoxetine: 4
3C Unpaired t test: t(28) = 0.9872, p= 0.3320 Vehicle: 15
Fluoxetine: 15
3D Two-way ANOVA:
Interaction: F(1,19) = 0.8761, p= 0.3610
Fluoxetine: F(1,19) = 2.627, p= 0.1216
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using chemiluminescent western blotting substrate in Fuji LAS3000
camera (TamroMedlabs).
ELISA
Levels of pTRKB were evaluated using ELISA for pTRKB developed in
our lab (Antila et al., 2014). On day 1, the high-binding 96-well
OptiPlate (PerkinElmer) was incubated overnight at 4°C with 1:500 anti-
TRKB antibody diluted in a homemade carbonate buffer (57.4 mM so-
dium bicarbonate and 42.6 mM sodium carbonate, pH9.8). On day 2,
the plate was incubated for 2 h at RT in the blocking buffer (3% BSA in
PBST) to block non-specific binding. Homogenized and centrifuged
brain samples or lysed cell samples were added to the plate and incu-
bated overnight at 4°C. On day 3, the plate was washed four times with
PBST using an automated plate washer (Thermo Fisher Scientific
Wellwash Versa), and the samples were incubated in anti-phosphotyro-
sine or anti-pTRKB antibodies diluted 1:1000 in the blocking buffer
overnight at 4°C. On day 4, the samples were washed four times in
PBST and incubated with tertiary HRP-conjugated antibodies in the
blocking buffer (1:5000) at RT for 1 h. Finally, ECL was added to the
plate and luminescence was measured with 1-s integration time using
Varioskan Flash plate reader (Thermo Fisher Scientific). Levels of
TRKB:PTPs interaction were evaluated by ELISA using a similar proto-
col. TRKB was captured using anti-TRKB antibodies, and anti-PTPs
were applied afterward to assess levels of PTPs bound to TRKB.
Cell-surface ELISA
Cell-surface ELISA was conducted to assess PTPs levels found on the
cell surface as previously described (Zheng et al., 2008; Fred et al., 2019).
Briefly, cortical cells were cultivated in clear-
bottom 96-well plates (ViewPlate 96,
PerkinElmer). On 7 DIV, the cells’ medium
was removed, washed with cold PBS, and
fixed with 100ml of 4% paraformaldehyde
(PFA) per well for 20min. Then the cells were
washed with PBS three times, and non-spe-
cific binding was blocked with PBS containing
5% non-fat dry milk and 5% BSA for 1 h at
RT. After that, the samples were incubated in
primary anti-PTPs antibody (1:500 in the
blocking buffer) overnight at 4°C. On the fol-
lowing day, the cells were washed with PBS
once and incubated in HRP-conjugated anti-
mouse antibody (1:5000 in the blocking
buffer) for 1 h at RT. The cells were washed
four times with PBS, ECL was added and
chemiluminescence was measured with 1-s
integration time using Varioskan Flash
(Thermo Fisher Scientific).
Transparent skull surgery
Transparent skull surgery was conducted as
described previously (Steinzeig et al., 2017).
Animals were anesthetized either with a mix-
ture of 0.05mg/kg fentanyl (Hameln), 5mg/
kg midazolam (Hameln), and 0.5mg/kg
medetomidine (Orion Pharma) administered
intraperitoneally or isoflurane combined with
0.05mg/kg buprenorphine analgesia adminis-
tered subcutaneously, 5mg/kg carprofen
(ScanVet) was administered subcutaneously
for postoperative analgesia. Under anesthesia,
the scalp and periosteum of the animals were
removed, the skull was polished, and two
layers of transparent acryl powder (EUBECOS)
mixed with methyl methacrylate liquid
(Dentsply) were applied on the surface. Metal
holders (Neurotar) were installed on the top of
the head and fixed with a mixture of acryl poly-
mer powder (Dentsply) and cyanoacrylate glue
(Steinzeig et al., 2017).
Monocular deprivation (MD)
MD was conducted by suturing the eye contralateral to the imaged
hemisphere (left eye) with perma-hand silk thread (Ethicon). The length
of the MD was 3.5 d for the PTPs1/ versus WT experiment and 7 d for
the PV-TRKB1/ versus WT experiment. The integrity of the suture
was checked on a daily basis before the lights were on.
Optical imaging
Optical imaging of intrinsic signals was conducted as previously
described (Steinzeig et al., 2017). Visual cortex of the right hemisphere
of each animal was imaged. Continuous-periodic stimulation with con-
tinuous synchronized data acquisition was used for the processing of the
intrinsic signals. A drifting thin horizontal bar 2° wide moving upwards
with a temporal frequency of 1 cycle/8.3 s (0.125Hz) and a spatial fre-
quency of 1/80° was used to alternatively stimulate the left and right eye,
while the other eye was patched. The drifting bars were displayed 15°
to 15° from the center to optimally stimulate the binocular area of the
right visual cortex. The imaging was done under 1.2% isoflurane anes-
thesia in a 1:2 mixture of O2:air.
Optical imaging of PV-TRKB1/ mice
Four-month-old mice were used for the experiments. During week 1,
the animals underwent transparent skull surgery. After 7 d, during week
2, the animals underwent the first session of the optical imaging under
isoflurane anesthesia (IOS1). During week 3, the animals were injected
with 50 mU of chABC in PBS or PBS into the binocular area of the visual
Figure 1. ChABC-induced plasticity requires intact TRKB signaling in PV1 neurons. A, PNN removal by local chABC injection
reopens critical period-like plasticity in the visual cortex of WT but not in mice heterozygous for TRKB deletion in PV interneurons
(PV-TRKB1/), as measured by optical imaging of the intrinsic signal before (IOS1) and after 7 d of MD (IOS2). ODI: ocular dominance
index. B, ChABC treatment (30min) of cortical neurons (7 DIV) increases pTRKB. C, The CSPG aggrecan, added to cortical neurons (6
DIV) for 24 h, attenuates BDNF-induce pTRKB in cortical neurons. Columns and bars represent mean6 SEM, respectively, and scat-
tered points represent individual values. Data were analyzed by three-way ANOVA and Tukeys’s post hoc (A), Mann–Whitney (B), or
two-way ANOVA followed by Tukey’s multiple comparison test (C); pp, 0.05, ppp, 0.005, pppp, 0.0005.
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cortex and were subjected to MD for 7 d. During week 4, the eyes were
opened, and IOS2 immediately took place.
Optical imaging of PTPs1/mice
Two-month-old mice were used for the experiments. During week 1, the
animals underwent transparent skull surgery. After 7 d, the animals
underwent the first session of the optical imaging (IOS1) followed by
MD for 3.5 d. We have switched to the shorter MD length as compared
with the previously described experiment since it has been recently dem-
onstrated to be sufficient for the induction of the critical period-like plas-
ticity (Baho et al., 2019). On day 4 of the MD, the eyes were opened, and
IOS2 took place.
Stereotaxic surgeries
The mice were anesthetized with isoflurane combined with 0.05mg/kg
buprenorphine analgesia. Images acquired during the first session of the
optical imaging were used to identify the binocular area of the visual cor-
tex. A hole in the skull was made with a drill, and 50 mU of chABC in
1ml of PBS or 1ml of PBS was injected in the center of the binocular area
using a microsyringe pump; 10-ml Nanofil syringe (WPI Nanofil) with
drilled 1.1-mm outlet bore to accommodate 1.0-mm glass needle and
custom-made bevelled borosilicate glass needles with a 50-mm tip diame-
ter were used for the infusions. Infusions were done at the speed of 2 nl/
s. After the surgery, the animals were left to recover in the home cage,
and the second imaging session took place 7 d later.
Experimental design and statistical analysis
The experiments were designed taking into account good laboratory
practices and the 3Rs principle of animal research. Both sexes of mice
were used in all the experiments involving animal testing, except for the
in vivo fluoxetine experiment (samples from only male mice were used
because of a low number of female mice available in the cohort).
Parametric tests were preferentially used to gain statistical power.
Exceptions were made whenever the data presented lacked homoscedas-
ticity or when variables were discrete, in which cases non-parametric
tests were chosen. The statistical tests used in each particular experiment
and statistical values are described in the legend of figures, and statistical
values are provided in Table 1. Differences were considered statistically
significant when p, 0.05. Statistical analysis and plots were made in
GraphPad Prism 6 software. Data are presented as mean 6 SEM.
Detailed information on the statistical analysis of each experiment, and
number of samples/animals used is given in Table 1.
Results
TRKB signaling in PV1 neurons is essential for chABC-
induced plasticity
Digestion of PNNs by chABC is a well-known activator of plas-
ticity (Fawcett et al., 2019), and it has been shown to induce criti-
cal period-like plasticity in the adult rodent visual cortex through
Figure 2. Deletion of CSPG receptor PTPs facilitates pTRKB and delays closure of the critical period in the visual cortex of adult mice. A, PTPs can be immunoprecipitated with anti-TRKB
antibody in samples from a TRKB-expressing, but not from a TRKA-expressing, cell line. B, Interaction of TRKB and PTPs is reduced in embryonic cortical cultures from PTPs1/ mice when
compared with those from WT mice. C, pTRKB is increased in cortical cultures from PTPs1/ and PTPs/ mice. D, Adult PTPs1/ mice have increased pTRKB and (E) a slight decrease in
total TRKB levels in the visual cortex. F, Critical period-like plasticity is present in the visual cortex of two-month-old PTPs1/ mice (red circles) but not in WT littermates (black squares), as
measured by optical imaging of the intrinsic signal before (IOS1) and after 3.5 d of MD (IOS2). ODI: ocular dominance index. Columns and bars represent mean6 SEM, respectively, and scat-
tered points represent individual values. Data were analyzed by two-way (F) or one-way ANOVA (C) followed by Bonferroni’s or Tukey’s post hoc, respectively; unpaired t test (B) or Mann–
Whitney test (D, E); pp, 0.05, ppp, 0.005, pppp, 0.0005.
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degradation of CSPGs in the extracellular matrix (Pizzorusso et
al., 2002). However, precise molecular mechanisms responsible
for the plasticity-promoting effect of chABC remain largely
unknown.
We tested the hypothesis that TRKB functioning in PV1
interneurons is involved in chABC-induced plastic changes. For
that purpose, we generated mice heterozygous for full-length
TRKB allele in PV1 interneurons (PV-TRKB1/; Minichiello et
al., 1999). We assessed the ability of chABC to promote ocular
dominance plasticity in their visual cortex. Four-month-old mice
underwent assessment of their ocular dominance by optical
imaging of the intrinsic signal (IOS1; Cang et al., 2005; Steinzeig
et al., 2017). After the first imaging session, the mice were
injected with chABC or vehicle into the binocular area of the vis-
ual cortex followed by MD for 7 d. As expected, vehicle-treated
WT mice failed to show any OD plasticity in the second imaging
session (IOS2) right after the MD, whereas WT mice treated
with chABC showed a clear shift in the ocular dominance toward
the non-deprived eye (Fig. 1A), as previously shown (Pizzorusso
et al., 2002). However, PV-TRKB1/ mice failed to show any
shift in ocular dominance regardless of whether they were treated
with chABC or not (Fig. 1A). These data demonstrate that
chABC-mediated reactivation of visual cortical plasticity is de-
pendent on intact TRKB signaling in the PV1 interneurons.
Next, we assessed whether PNN digestion with chABC indu-
ces TRKB activation in primary cerebral cortical neurons. We
treated rat cortical neurons grown in vitro (DIV) for 7d with 2 U/
ml chABC for 30min and checked the activation
of TRKB by assessing its phosphorylation levels
(pTRKB; Antila et al., 2014). We observed that
reduction of PNNs by chABC treatment
robustly increased pTRKB in vitro (Fig. 1B).
After observing that PNN digestion with
chABC treatment positively affects pTRKB, we
investigated whether treatment with aggrecan,
a major PNN component in the adult CNS,
might have an opposing effect on pTRKB and
render BDNF-induced TRKB activation less
effective. We added 10mg/ml aggrecan to the
primary cortical neurons cultured for 6 DIV.
After 24 h, we challenged the cells with 20ng/
ml BDNF for 10min. Aggrecan treatment did
not alter basal pTRKB levels (that are normally
very low in vitro); however, it significantly
decreased BDNF-induced pTRKB (Fig. 1C).
Taken together, these data demonstrate that
PNNs regulate plasticity in a TRKB-dependent
manner in vivo and that PNNs exert negative
effects on TRKB activation in vitro.
Deletion of CSPG receptor PTPr extends
the critical period and facilitates TRKB
activation
PTPs is a recognized inhibitor of neuronal
plasticity and a receptor for CSPGs (Shen et
al., 2009; Duan and Giger, 2010; Fawcett et
al., 2019), and previous data indicate that
PTPs interacts with TRKB (Kurihara and
Yamashita, 2012). We therefore hypothesized
that PTPs might restrict TRKB signaling
through dephosphorylation in PNN-bearing
PV1 interneurons and thereby inhibit TRKB-
promoted plasticity. To confirm TRKB:PTPs
interaction, NIH3T3 cell line stably express-
ing either TRKA or TRKB (MG.TRKA and MG.TRKB, respec-
tively), were transfected with myc-PTPs , immunoprecipitated
with anti-TRKB antibody and blotted for PTPs . In the trans-
fected samples, we observed a band below 250 kDa (Fig. 2A),
which is consistent with the predicted molecular weight of the
plasmid’s product. Additionally, a 165-kDa band was observed in
non-transfected cells, which corresponds to the endogenous
mature full-length PTPs (Faux et al., 2007). When the membrane
was stripped and reblotted for TRKB, we observed a band of 140
kDa corresponding to the full-length TRKB. This band was seen
in TRKB expressing cells only, which rules out potential unspecific
binding of TRKB antibodies to TRKA receptors. These data indi-
cate that PTPs interacts with TRKB. Furthermore, our previous
proteomic study found PTPs among the proteins that were
immunoprecipitated with TRKB in hippocampal samples of the
adult mouse brain (Fred et al., 2019).
Next, we set out to investigate the role of PTPs in pTRKB by
using mice heterozygous for PTPs (PTPs1/). Since transgenic
mice quite often develop compensatory mechanisms to counter-
act genetic deficiency, we wanted to confirm that neurons lack-
ing PTPRS allele would present comparable reduction in PTPs :
TRKB protein interaction. We prepared E18 neuronal cultures
from cortex of WT or PTPs1/ littermates, and compared them
after 7 DIV using co-immunoprecipitation. We observed a
reduction of ;50% in the interaction between TRKB and PTPs
in samples from PTPs1/ mice as compared with WT (Fig. 2B).
Figure 3. Fluoxetine disrupts TRKB and PTPs interaction in vitro and in vivo. A, Fluoxetine (FLX) disrupts the inter-
action between TRKB and PTPs in 7 DIV cortical neurons, and (B) in the visual cortex (V1) of mice systemically
treated (30 mg/kg, i.p.) 30min before tissue dissection. C, Fluoxetine does not affect the detection of PTPs extracellu-
lar domain on the cell surface, indicating no effect on PTPs surface exposure or PTPs ectodomain shedding. D,
Mutation of the TRKB transmembrane domain (R427A/Y433F) partially disrupts the TRKB:PTPs interaction and abol-
ishes the effects of fluoxetine on it. Columns and bars represent mean 6 SEM, respectively. Data were analyzed by
one-way ANOVA followed by Bonferroni’s (A), two-way ANOVA (D), or unpaired t test (B, C); pp, 0.05,
ppp, 0.005.
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Then, we further investigated whether PTPs influences pTRKB.
We compared cortical pTRKB levels in embryonic cultures from
PTPs/ and PTPs1/ mice with those in cultures prepared
from their WT littermates. Notably, PTPs had a clear gene dos-
age-dependent suppressive effect on the basal pTRKB. PTPs1/
cortical cultures demonstrate increased pTRKB as compared
with cultures from their WT littermates, and PTPs/ samples
demonstrate yet further increased pTRKB significantly differing
from both PTPs1/ andWT samples (Fig. 2C). We also checked
the levels of pTRKB in samples from the adult visual cortex of
mice heterozygous for PTPRS gene (PTPs1/). In line with our
in vitro data, adult PTPs1/ mice exhibit increased basal TRKB
autophosphorylation in the visual cortex (Fig. 2D), despite hav-
ing slightly reduced levels of total TRKB (Fig. 2E), which may
represent a compensatory downregulation because of a long-
term increase in pTRKB.
Finally, we investigated whether increased TRKB signaling
produced by genetic deficiency of PTPs might render the corti-
cal structures of PTPs1/ mice susceptible to plastic changes.
We tested adult PTPs1/ mice and their WT littermates in an
ocular dominance plasticity paradigm using optical imaging. As
expected, MD did not induce an ocular dominance shift in adult
WT animals; however, it did induce a shift in ocular dominance
in PTPs1/ mice (Fig. 2F), indicating that closure of the critical
period was delayed or prevented in the PTPs1/ mice.
Antidepressant treatment disrupts TRKB:PTPr interaction
Antidepressants have been demonstrated to induce activation of
TRKB receptors in the brain (Saarelainen et al., 2003; Rantamäki
et al., 2007; Castrén and Rantamäki, 2010). Moreover, fluoxetine,
a widely used antidepressant, induces ocular dominance plastic-
ity in the adult visual cortex through BDNF-TRKB signaling
(Maya Vetencourt et al., 2008) and reduces percentage of PNNs
enwrapping PV1 interneurons in the amygdala and hippocam-
pus, shifting PV1 interneurons toward an immature state and
reopening brain plasticity (Karpova et al., 2011). Therefore, we
asked whether fluoxetine treatment might have an effect on
TRKB:PTPs interaction, which could potentially establish a link
between antidepressant-induced pTRKB and PNNs. We cultured
rat primary cortical neurons for 7 DIV and challenged them with
two different doses of fluoxetine (0.1 and 1 mM) for 30min.
Fluoxetine dose-dependently reduced the interaction between
TRKB and PTPs in vitro as measured by ELISA (Fig. 3A). Since
fluoxetine has been shown to increase pTRKB as fast as 30min
after systemic injection (Saarelainen et al., 2003), we checked
whether fluoxetine would be able to disrupt TRKB:PTPs inter-
action in vivo within a similar timeframe. We treated animals
with 30mg/kg fluoxetine (intraperitoneally) and killed the ani-
mals 30min after the injection. Acute fluoxetine treatment sig-
nificantly reduced TRKB:PTPs interaction in vivo (Fig. 3B).
PTPs is proteolytically processed by cleavage in the juxta-
membrane region, leading to shedding of the extracellular do-
main (Faux et al., 2007). To rule out the possibility that TRKB:
PTPs interaction experiments could have been influenced by a
potential effect of the treatment on PTPs shedding, we investi-
gated the presence of PTPs extracellular domain in the cell sur-
face after fluoxetine treatment in cortical cells using cell-surface
ELISA (Zheng et al., 2008; Fred et al., 2019). We found no effect
of the drug (Fig. 3C). These data indicate that fluoxetine does not
affect PTPs shedding and positioning on cell surface, and sup-
ports the idea that the decrease in PTPs levels in co-IP experi-
ments is a result of decreased interaction with TRKB.
Antidepressants have recently been shown to directly interact
with TRKB through the transmembrane region (Casarotto et al.,
2019). Moreover, it has been previously suggested that PTPs
interacts with TRKA receptors through its transmembrane
region (Faux et al., 2007). Therefore, we asked whether disrup-
tion in TRKB:PTPs interaction after fluoxetine treatment is
potentially mediated by the antidepressant’s binding to the same
region of TRKB where interaction with PTPs takes place. We
transfected HEK293T cells with either a WT TRKB plasmid or a
TRKB plasmid carrying two point mutations in the transmem-
brane region of TRKB (arginine R427 mutated to alanine,
R427A; and tyrosine Y433 mutated to phenylalanine, Y433F);
these point mutations disrupt a cholesterol interaction site in the
TRKB transmembrane region critical for antidepressant interac-
tion (Cannarozzo et al., 2020). R427A/Y433F mutation caused a
dramatic decrease in TRKB:PTPs interaction levels, however,
the interaction was not completely lost, suggesting that multiple
sites of interaction may exist. Nevertheless, fluoxetine (10 mM)
failed to influence TRKB:PTPs interaction in the cells carrying
R427A/Y433F mutated TRKB (Fig. 3D), providing evidence that
the site of interaction of PTPs and fluoxetine with TRKB lies
within the transmembrane region of TRKB.
Discussion
In the current study, we have investigated a possible convergence
of the two plasticity-inducing methods, chABC and antidepressant
Figure 4. Schematic model of how chondroitinase and antidepressant treatments promote plasticity by releasing TRKB from dephosphorylating control of PTPs . Left, In the presence of
PNNs, active PTPs dephosphorylates TRKB and suppresses its signaling. Middle, In the absence of PNNs, PTPs is inactive and pTRKB is facilitated. Right, Fluoxetine (FLX) disrupts TRKB:PTPs
interaction, promoting TRKB signaling.
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treatment, on the same molecular pathway involving reduced de-
phosphorylation of TRKB by PTPs within PV1 interneurons.
PNNs, extracellular structures rich in CSPGs, are associated with a
reduction of plasticity in the adult brain. Maturation of PNNs
coincides with the closure of the critical period (Berardi et al.,
2004; Fawcett et al., 2019), and digestion of PNNs has been shown
to promote plasticity and re-open critical periods for certain func-
tions in the adult nervous system (Fawcett et al., 2019). Local
injections of chABC promote axonal regeneration and functional
recovery after spinal cord injury (Bradbury et al., 2002), restore oc-
ular dominance plasticity in the visual cortex (Pizzorusso et al.,
2002), and promote extinction of fear memories in rodents
(Gogolla et al., 2009). PNNs preferentially enwrap PV1 interneur-
ons that synchronize oscillatory activity of brain networks and
mediate neuronal plasticity and learning. Our experiments dem-
onstrate that the effects of chABC depend on TRKB signaling in
PV1 interneurons, since genetic deficiency of TRKB in PV1 cells
abrogates the ability of chABC to induce plasticity in the visual
cortex of adult mice. Moreover, we have shown that chABC treat-
ment increases pTRKB, which promotes TRKB signaling, while
treatment with CSPG aggrecan decreases phosphorylation of
TRKB induced by BDNF.
CSPGs, major components of PNNs, have been shown to
exert inhibitory action on plasticity through protein tyrosine
phosphatase receptor type S (Shen et al., 2009). PTPs has been
demonstrated to be critical for the inhibitory effects of CSPGs on
plasticity and regeneration since CSPGs exert little inhibitory
effect on axonal outgrowth of neurons prepared from PTPs/
mice as compared with WT (Shen et al., 2009). Interestingly,
PTPs has been shown to interact with and dephosphorylate all
three TRK receptors and inhibit their activation even in the pres-
ence of their cognate neurotrophins (Faux et al., 2007). Faux et
al. (2007) provided evidence that PTPs forms stable complexes
with TRKA and TRKC and only weakly interacts with TRKB.
However, subsequent research has shown that PTPs co-immu-
noprecipitates with TRKB in samples from cortical neurons and
mediates abrogation of BDNF-induced dendritic spine formation
by CSPGs (Kurihara and Yamashita, 2012). We have now dem-
onstrated that PTPs dephosphorylates TRKB in vitro and in
vivo based on increased phosphorylation of TRKB in cultures
prepared from PTPs KO homozygous or heterozygous mice
(PTPs/ and PTPs1/) and in samples from the visual cortex
of PTPs1/ mice. Moreover, we observed that genetic deficiency
of PTPs delays the closure of critical period-like plasticity in the
adult visual cortex, an effect that we demonstrated to be depend-
ent on TRKB in PV1 neurons.
TRKB signaling is known to be critical for activation of plas-
ticity by antidepressant drug treatment and for the behavioral
consequences of it (Saarelainen et al., 2003; Duman and
Monteggia, 2006; Autry and Monteggia, 2012; Castrén and
Antila, 2017). Moreover, our group has recently demonstrated
that TRKB activation in PV1 interneurons is sufficient for the
induction of juvenile-like plasticity in the adult brain and neces-
sary for the plasticity-inducing effects of fluoxetine (Winkel et
al., 2020). We now demonstrate that the antidepressant fluoxe-
tine induces disruption of interaction between TRKB and PTPs ,
releasing TRKB from the suppressive activity of the phosphatase
and promoting its activation (Fig. 4). These data suggest that
reduced dephosphorylation of TRKB by PTPs is at least one
mechanism through which antidepressant treatment promotes
plasticity.
Antidepressants have recently been shown to directly interact
with TRKB through its transmembrane domain (Casarotto et al.,
2021). Our data now show that the mutation that inhibits antide-
pressant binding to the transmembrane region of TRKB partially
disrupts its interaction with PTPs , and that fluoxetine treatment
has no further additive effect on TRKB:PTPs interaction in
TRKB mutant cells. These data suggest that TRKB and PTPs
interact in the transmembrane region of TRKB, and that binding
of fluoxetine to TRKB disrupts TRKB:PTPs interaction.
Our findings suggest a general mechanism responsible for
the opening of critical period-like plasticity in the adult brain
by chABC and antidepressant treatment (Fig. 4). We propose
that both methods converge on the same pathway involving
reduced inhibitory interaction between TRKB and PTPs in
PV1 neurons, which releases TRKB from the PTPs -mediated
dephosphorylation and promotes its autophosphorylation.
Chondroitinase treatment downregulates CSPG-mediated
activation of PTPs , which allows for enhanced signaling of
TRKB (Fig. 4). Antidepressants, on the other hand, disrupt the
interaction between TRKB and PTPs in the membrane, pro-
moting TRKB activation (Fig. 4).
Taken together, our data reveal that interaction between
TRKB and PTPs in PV1 interneurons is a critical regulator of
chABC-induced and antidepressant-induced plasticity in the
adult cortex. The similarity in the plasticity-promoting effects of
chABC and antidepressants prompted us to focus on these two
treatments, but there are a number of other methods known to
reactivate juvenile-like plasticity in the adult cortex (Bavelier et
al., 2010), such as enriched environment (Nithianantharajah and
Hannan, 2006; Sale et al., 2007, 2014) and cross-modal manipu-
lation of sensory functions (Rodríguez et al., 2018). It will be
interesting in future studies to investigate whether induction of
plasticity by these means recruits the same molecular pathways
involving enhanced TRKB activation in PV1 interneurons.
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